E-DRUG Archives (by date)

• Thread Index

November 29, 2001
• [e-drug] Dispensing devices for patients
  • From: "D.Rowed" <drowed@bigpond.net.au>
• [e-drug] Virus warning
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Re: Tablet/capsule counting machines? (cont)
  • From: "Michel LALOGE" <mlaloge@free.fr>
• [e-drug] Re: Tablet/capsule counting machines? (cont)
  • From: Erik Fred Oscar Pomp <efpo@haukeland.no>
• [e-drug] Affordable Medicines and Treatment Campaign
  • From: "HIV Aids Unit" <aidslaw1@del2.vsnl.net.in>
• [e-drug] Re: Tablet/capsule counting machines?
  • From: kbessell@signet.com.au
November 28, 2001
• [e-drug] Aubrey Sheiham Cochrane Scholarship
  • From: Joy.Oliver@mrc.ac.za
• [e-drug] Tablet/capsule counting machines?
  • From: did.jms@imul.com
November 27, 2001
• [e-drug] Video News Releases
  • From: Alan Cassels <alan@alancassels.com>
• [e-drug] Contents of Prescrire Internatonal, December 2001
  • From: international@prescrire.org
• [e-drug] European conference on antibiotic use
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Drug Policy Issues courses
  • From: richardl@bu.edu
• [e-drug] " Massive Effort Against Diseases of Poverty in Moldova. Access to
  • From: "DrugInfo Moldova" <office@drugs.mldnet.com>
• [e-drug] Re: Evaluation of brand names (cont)
  • From: mojoo@gerties.org
November 25, 2001
• [e-drug] Parameter for assessing longer-term efficacy of antiretroviral
  • From: e-drug@usa.healthnet.org
• [e-drug] Scientist used Indian patients as guinea pigs
  • From: e-drug@usa.healthnet.org
• [e-drug] Controversy over vitamin A programme in India
  • From: e-drug@usa.healthnet.org
November 24, 2001
• [e-drug] Breast cancer pictures
  • From: Dr N Gyasi Agyei <gyasi@kingsley.co.za>
• [e-drug] Generic omeprazole (7)
  • From: Kirsten Myhr <kirsten.myhr@relis.ulleval.no>
• [e-drug] HIV and drug interactions
  • From: Kirsten Myhr <kirsten.myhr@relis.ulleval.no>
November 23, 2001
• [e-drug] Potency of benzathine benzylpenicillin
  • From: Kirsten Myhr <kirsten.myhr@relis.ulleval.no>
• [e-drug] Kenya Can Benefit From Looser Patent Restrictions on Drugs
  • From: e-drug@usa.healthnet.org
• [e-drug] Activists: Global Fund betrays people with AIDS
  • From: "Sharonann Lynch" <salynch00@earthlink.net>
November 22, 2001
• [e-drug] actual Doha TRIPS&public health declaration
  • From: e-drug@usa.healthnet.org
• [e-drug] EU to set record fines for vitamin cartel
  • From: e-drug@usa.healthnet.org
November 21, 2001
• [e-drug] Terms you may come across
  • From: Christian Nordqvist <CNordqvist@aol.com>
• [e-drug] Research in a missionary setting
  • From: Nfor Emmanuel Y <hospital_banso@kastanet.org>
• [e-drug] Direct to consumer promotion and the EU
  • From: Lisa Hayes <lisa@hai.antenna.nl>
• [e-drug] Low Cost Medical Waste Incineration
  • From: Mike Bennett <edtc@globalnet.co.uk>
• [e-drug] Seminar on Contraceptive Security
  • From: Heather Davis <heather_davis@jsi.com>
• [e-drug] Kava Kava (2)
  • From: Fritz Steinhausen <K.F.Steinhausen@t-online.de>
• [e-drug] Kava Kava (3)
  • From: Beverley Snell <bev@burnet.edu.au>
November 20, 2001
• [e-drug] Kava Kava
  • From: Larry Sasich <LSASICH@citizen.org>
• [e-drug] books on CD-ROM? (2)
  • From: Ansie Kruger <ansi101@intekom.co.za>
• [e-drug] Bredell Consensus Statement on Anti-retrovirals
  • From: Andy Gray <agray@pixie.udw.ac.za>
• [e-drug] Evaluation of brand names (3)
  • From: Sjukehusapoteket Elverum <sjappe@apotek.no>
• [e-drug] access to anti-retrovirals in South Africa
  • From: e-drug@usa.healthnet.org
• [e-drug] Evaluation of brand names (2)
  • From: Janet.Robertson@gstt.sthames.nhs.uk
• [e-drug] offer of medical journals, update (2)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] books on CD-ROM?
  • From: Wilbert Bannenberg <wbannenberg@un.org.za>
• [e-drug] Global Solidarity in S. A.'s MTCT Court Case
  • From: colwynp@mweb.co.za
• [e-drug] South African court case on MTCT/Nevirapine
  • From: e-drug@usa.healthnet.org
November 19, 2001
• [e-drug] offer of medical journals, update
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Open patent licensing of public funded research (2)
  • From: Warren Kaplan <wak22@mediaone.net>
• [e-drug] diabetes drugs
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] teicoplanin (2)
  • From: Mohamad Haniki <haniki@usm.my>
• [e-drug] Evaluation of brand names
  • From: sanjay sogali <sanjay_dbph@yahoo.com>
• [e-drug] Open patent licensing of public funded research
  • From: Christian Labadie <labc@medizin.uni-leipzig.de>
November 18, 2001
• [e-drug] Generic omeprazole (6)
  • From: Kirsten Myhr <kirsten.myhr@relis.ulleval.no>
November 16, 2001
• [e-drug] teicoplanin
  • From: Daniel Tchercansky <dtcherca@ffyb.uba.ar>
• [e-drug] Generic omeprazole (5)
  • From: Carine Werder <carinewerder@yahoo.co.uk>
• [e-drug] RFI: Scientific basis for defining non-adherence (2)
  • From: John Urquhart <urquhart@ix.netcom.com>
• [e-drug] Generic omeprazole (4)
  • From: Janet Robertson <janet.robertson@gstt.sthames.nhs.uk>
• [e-drug] Access to drug evaluations (3)
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Wash Post: Activists, Developing Nations Make Gains
  • From: e-drug@usa.healthnet.org
• [e-drug] Doha responses from Act-Up, EU, PhRMA
  • From: e-drug@usa.healthnet.org
• [e-drug] Access to drug evaluations (2)
  • From: Mohamad Haniki <haniki@usm.my>
November 15, 2001
• [e-drug] Global Alliance for TB Drug Development
  • From: Joelle Tanguy <joelle.tanguy@tballiance.org>
• [e-drug] Access to drug evaluations
  • From: Arne Royce Cahilg<cahilig@yahoo.com>
• [e-drug] Joint press statement on Doha outcome
  • From: Ingrid Cox<Ingrid_COX@msf.org>
• [e-drug] Generic omeprazole (3)
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Generic omeprazole (2)
  • From: Atieno Ojoo <mojoo@gerties.org>
• [e-drug] Parallel Importation (2)
  • From: Elena Romano <eromano@equinox-group.com>
• [e-drug] Generic omeprazole
  • From: Vanesa Honisch <honischv@yahoo.com>
• [e-drug] Parallel Importation
  • From: Dennis Rosete <ndic@pacific.net.ph>
November 14, 2001
• [e-drug] Tobacco company and lung cancer vaccines
  • From: Beverley Snell <bev@burnet.edu.au>
November 13, 2001
• [e-drug] Doha news on patents and drugs
  • From: e-drug@usa.healthnet.org
• [e-drug] WTO Declaration on TRIPS and health
  • From: Olivier Jablonski <jablonski@altern.org>
November 12, 2001
• [e-drug] RFI: Scientific basis for defining non-adherence
  • From: Andy Gray <agray@pixie.udw.ac.za>
November 11, 2001
• [e-drug] TRIPS: will the majority prevail?
  • From: Olivier Jablonski <jablonski@altern.org>
• [e-drug] Lancet editorial on TRIPS and access to medicines
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] New article on ciprofloxacin side effects
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
November 10, 2001
• [e-drug] Letter to USTR Zoellick re. WTO Patent discussions
  • From: James Love <love@cptech.org>
November 09, 2001
• [e-drug] Joint press statement MSF, Oxfam, and TWN
  • From: Ingrid_COX@msf.org
November 08, 2001
• [e-drug] US allows South Africa to Ignore Patents for 5 years
  • From: e-drug@usa.healthnet.org
• [e-drug] NEJM update on anthrax
  • From: Kirsten Myhr <myhr@online.no>
November 07, 2001
• [e-drug] WHO Report on Infectious Disease (2)
  • From: Daniel Seyoum <dws@usp.org>
November 06, 2001
• [e-drug] Pharma Lobby and US Bioterror Plan
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] Europ. Parl. resolutions on AIDS and WTO
  • From: Gerard Seco <Seco_GERARD@msf.org>
November 05, 2001
• [e-drug] E-drug: World Health Organization Report on Infectious Disease
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] E-drug moderator switch
  • From: Hilbrand Haak <haakh@compuserve.com>
• [e-drug] Pharma Lobby and US Bioterror Plan
  • From: E-drug <e-drug@usa.healthnet.org>
November 04, 2001
• [e-drug] Uganda drug supply system study
  • From: Chris Forshaw <chris.hssp@imul.com>
• [e-drug] Japanese drugs (cont'd)
  • From: Elena Romano <eromano@equinox-group.com>
November 01, 2001
• [e-drug] Therapeutics Letter 42 now on the web
  • From: Ciprian Jauca <jauca@ti.ubc.ca>